by Richard Daverman, PhD
October 15, 2012 -- Shanghai has established an institute for advanced immunochemical studies, sponsored by Shanghai Tech University and the Shanghai Advanced Research Institute under the Chinese Academy of Sciences. Its goal is to advance antibody drug R&D. Richard Lerner, MD, a research chemist who recently stepped down after twenty years as head of The Scripps Research Institute, was named the institute’s first director. Lerner will lead a team of experts from the US, Europe and China. More details....
